• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[骨血管轴共病研究中动物模型的进展]

[Advances in Animal Modeling in the Study of Bone-Vascular Axis Comorbidities].

作者信息

Li Jiayang, Zhou Yumeng, Luo Yuwen, Huang Xuelin, Zhang Demao, Liu Xiaoheng

机构信息

( 610041) Institute of Biomedical Engineering, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu 610041, China.

出版信息

Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):355-363. doi: 10.12182/20250360504.

DOI:10.12182/20250360504
PMID:40599294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12207050/
Abstract

Osteoporosis and cardiovascular calcification, two major age-related chronic diseases that China is confronting today, pose serious threats to public health. Previous studies have reported overlapping connections in the pathological processes and molecular mechanisms of these two diseases, particularly concerning inflammation, oxidative stress, and dysregulation of mineral metabolism, and that these two diseases tend to share common pathogenic factors. However, research exploring the comorbidity mechanisms of the two diseases remains limited in both depth and scope, largely due to the lack of widely accepted comorbidity animal models. Herein, we analyzed the latest research findings on the comorbidity mechanisms of vascular calcification and osteoporosis, focusing on summarizing the animal disease models currently in extensive use and the relevant evaluation criteria. We aim to provide new references for comorbidity research models and offer scientific evidence for future studies on pathological mechanisms and the development of new therapeutic strategies.

摘要

骨质疏松症和心血管钙化是中国目前面临的两种主要的与年龄相关的慢性疾病,对公众健康构成严重威胁。先前的研究报告了这两种疾病在病理过程和分子机制上存在重叠联系,特别是在炎症、氧化应激和矿物质代谢失调方面,并且这两种疾病往往具有共同的致病因素。然而,探索这两种疾病合并症机制的研究在深度和广度上仍然有限,这主要是由于缺乏广泛接受的合并症动物模型。在此,我们分析了血管钙化和骨质疏松症合并症机制的最新研究结果,重点总结了目前广泛使用的动物疾病模型及相关评估标准。我们旨在为合并症研究模型提供新的参考,并为未来关于病理机制的研究和新治疗策略的开发提供科学依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d5/12207050/001e78c5e404/scdxxbyxb-56-2-355-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d5/12207050/1406d644f50c/scdxxbyxb-56-2-355-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d5/12207050/001e78c5e404/scdxxbyxb-56-2-355-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d5/12207050/1406d644f50c/scdxxbyxb-56-2-355-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74d5/12207050/001e78c5e404/scdxxbyxb-56-2-355-2.jpg

相似文献

1
[Advances in Animal Modeling in the Study of Bone-Vascular Axis Comorbidities].[骨血管轴共病研究中动物模型的进展]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):355-363. doi: 10.12182/20250360504.
2
Calcium and vitamin D for increasing bone mineral density in premenopausal women.钙和维生素 D 增加绝经前妇女的骨密度。
Cochrane Database Syst Rev. 2023 Jan 27;1(1):CD012664. doi: 10.1002/14651858.CD012664.pub2.
3
Parathyroidectomy for adults with primary hyperparathyroidism.甲状旁腺切除术治疗原发性甲状旁腺功能亢进症成人患者。
Cochrane Database Syst Rev. 2023 Mar 8;3(3):CD013035. doi: 10.1002/14651858.CD013035.pub2.
4
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.利塞膦酸钠用于绝经后妇女骨质疏松性骨折的一级和二级预防。
Cochrane Database Syst Rev. 2022 May 3;5(5):CD004523. doi: 10.1002/14651858.CD004523.pub4.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Bisphosphonates for steroid-induced osteoporosis.双膦酸盐用于治疗类固醇诱导的骨质疏松症。
Cochrane Database Syst Rev. 2016 Oct 5;10(10):CD001347. doi: 10.1002/14651858.CD001347.pub2.
8
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.在没有明显临床指征的患者和常见合并症患者亚组中,在择期手术前常规检测全血细胞计数、电解质和尿素以及肺功能测试的价值:对临床和成本效益文献的系统评价。
Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500.
9
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).用于预防和治疗慢性肾脏病-矿物质和骨异常(CKD-MBD)的磷结合剂。
Cochrane Database Syst Rev. 2025 Jun 27;6(6):CD006023. doi: 10.1002/14651858.CD006023.pub4.
10
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.

本文引用的文献

1
GDF10 is a negative regulator of vascular calcification.生长分化因子10是血管钙化的负调节因子。
J Biol Chem. 2024 Nov;300(11):107805. doi: 10.1016/j.jbc.2024.107805. Epub 2024 Sep 21.
2
Interplay between bone marrow adiposity and bone resorption in RANKL-mediated modelled osteoporosis.RANKL介导的模拟骨质疏松症中骨髓脂肪与骨吸收之间的相互作用
J Cell Physiol. 2024 Dec;239(12):e31434. doi: 10.1002/jcp.31434. Epub 2024 Sep 15.
3
The Importance of Vitamin K and the Combination of Vitamins K and D for Calcium Metabolism and Bone Health: A Review.
维生素 K 的重要性以及维生素 K 和 D 的组合对钙代谢和骨骼健康的影响:综述。
Nutrients. 2024 Jul 25;16(15):2420. doi: 10.3390/nu16152420.
4
Augmentative effects of leukemia inhibitory factor reveal a critical role for TYK2 signaling in vascular calcification.白血病抑制因子的增强作用揭示了 TYK2 信号在血管钙化中的关键作用。
Kidney Int. 2024 Oct;106(4):611-624. doi: 10.1016/j.kint.2024.07.011. Epub 2024 Jul 30.
5
Orphan Nuclear Receptor NR4A3 Promotes Vascular Calcification via Histone Lactylation.孤儿核受体 NR4A3 通过组蛋白乳酰化促进血管钙化。
Circ Res. 2024 May 24;134(11):1427-1447. doi: 10.1161/CIRCRESAHA.123.323699. Epub 2024 Apr 17.
6
Novel Biomarkers of Bone Metabolism.新型骨代谢生物标志物。
Nutrients. 2024 Feb 22;16(5):605. doi: 10.3390/nu16050605.
7
Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification.4-羟基壬烯醛通过 K176 对 Runx2 的羰基化作用加速血管钙化。
Circulation. 2024 May 28;149(22):1752-1769. doi: 10.1161/CIRCULATIONAHA.123.065830. Epub 2024 Feb 13.
8
Heterogeneous osteoimmune profiles via single-cell transcriptomics in osteoporotic patients who fail bisphosphonate treatment.骨质疏松症患者双磷酸盐治疗失败后通过单细胞转录组学分析得出的异质骨免疫特征。
Proc Natl Acad Sci U S A. 2024 Feb 20;121(8):e2316871121. doi: 10.1073/pnas.2316871121. Epub 2024 Feb 12.
9
The Bone-Vascular Axis in Chronic Kidney Disease: From Pathophysiology to Treatment.慢性肾脏病中的骨-血管轴:从病理生理学到治疗。
Curr Osteoporos Rep. 2024 Feb;22(1):69-79. doi: 10.1007/s11914-023-00858-8. Epub 2024 Jan 10.
10
Early aging and premature vascular aging in chronic kidney disease.慢性肾脏病中的早衰和血管过早老化
Clin Kidney J. 2023 Apr 6;16(11):1751-1765. doi: 10.1093/ckj/sfad076. eCollection 2023 Nov.